Indeed, loss of BAF components, including dual loss of ARID1A and 1B, loss of SMARCB1, and loss of SMARCA4, are found in more than half of dedifferentiated and undifferentiated endometrial carcinoma, in a mutually exclusive manner [70,71]. This evidence concerns the gene ARID1A and endometrial carcinoma.